What the company does
Laseroptek makes laser-based devices used in cosmetic skin treatments and in treating medical conditions such as vitiligo (a skin pigmentation disorder).
Its products are used by clinics and medical professionals, and the company ships to customers across multiple countries. Listed on KOSDAQ, South Korea's tech-focused small-cap exchange, it has expanded from cosmetic lasers into therapeutic medical devices, and its product portfolio now spans both categories.
Summary is AI-generated and may contain errors · figures from DART filings
Financials
Source: DART · FY ending Dec · latest FY2025Revenue
- FY2023US$24.9M
- FY2024US$23.9M
- FY2025US$18.6M
Operating profit
- FY2023US$3.2M
- FY2024−US$142.1K
- FY2025−US$8.7M
Net income
- FY2023US$12.2K
- FY2024−US$567.6K
- FY2025−US$7.8M
Key ratios (FY2025)
Why it matters · Context, not a recommendation
The company developed what it describes as the world's first solid-state UVB laser device using titanium-sapphire crystal technology for vitiligo treatment, entering a market previously dominated by imported excimer devices.
Price charts coming soon
Interactive price history isn't here yet. Would you use it?